报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2023-03-31 | -11.29% | -637.91% | 85.83% | 117/122 | 2.21% | 迈瑞医疗 | 7.06% | 行业排名> |
2022-12-31 | -79.66% | -396.94% | -355.98% | 117/122 | 12.53% | 迈瑞医疗 | 31.95% | 行业排名> |
2022-09-30 | -17.47% | -11018.75% | -118.65% | 115/122 | 13.13% | 迈瑞医疗 | 28.68% | 行业排名> |
2022-06-30 | -7.99% | -505.58% | -422.22% | 116/122 | 9.35% | 迈瑞医疗 | 20.2% | 行业排名> |
2022-03-31 | -1.53% | -233.04% | 90.46% | 106/122 | 6.53% | 迈瑞医疗 | 9.12% | 行业排名> |
2021-12-31 | -16.03% | -1121.02% | -10118.75% | 116/122 | 17.08% | 迈瑞医疗 | 33.21% | 行业排名> |
2021-09-30 | 0.16% | -94.9% | -91.88% | 100/122 | 16.21% | 迈瑞医疗 | 28.34% | 行业排名> |
2021-06-30 | 1.97% | 49.24% | 71.3% | 104/122 | 11.49% | 迈瑞医疗 | 18.36% | 行业排名> |
2021-03-31 | 1.15% | 199.14% | -26.75% | 86/122 | 6.32% | 安杰思 | 8.56% | 行业排名> |
2020-12-31 | 1.57% | 302.56% | -50% | 107/122 | 25.31% | 九安医疗 | 146.56% | 行业排名> |
2020-09-30 | 3.14% | 5.72% | 137.88% | 76/122 | 19.72% | 九安医疗 | 140.94% | 行业排名> |
2020-06-30 | 1.32% | -24.57% | 213.79% | 96/122 | 15.2% | 九安医疗 | 142.25% | 行业排名> |
2020-03-31 | -1.16% | -152.02% | -397.44% | 72/122 | 3.27% | 九安医疗 | 142.71% | 行业排名> |
2019-12-31 | 0.39% | -80.98% | -86.87% | 101/122 | 8.52% | 热景生物 | 121.78% | 行业排名> |
2019-09-30 | 2.97% | -11.61% | 69.71% | 56/122 | 10.37% | 热景生物 | 99.69% | 行业排名> |
2019-06-30 | 1.75% | 2.94% | -21.52% | 64/122 | 6.65% | 热景生物 | 99.09% | 行业排名> |
2019-03-31 | 2.23% | -1.76% | 8.78% | 31/122 | 2.69% | 热景生物 | 57.63% | 行业排名> |
2018-12-31 | 2.05% | 0.99% | -38.99% | 92/122 | 13.88% | 中红医疗 | 168% | 行业排名> |
2018-09-30 | 3.36% | 13.9% | 97.65% | 48/122 | 9.53% | 圣湘生物 | 112.46% | 行业排名> |
2018-06-30 | 1.7% | 50.44% | -25.11% | 50/122 | 4.46% | DR博拓生 | 108.13% | 行业排名> |
2018-03-31 | 2.27% | 24.04% | 11.82% | 28/122 | 2.73% | 圣湘生物 | 29.33% | 行业排名> |
2017-12-31 | 2.03% | -33.88% | -31.19% | 89/122 | 14.13% | 健尔康 | 84.09% | 行业排名> |
2017-09-30 | 2.95% | -67.33% | 161.06% | 43/122 | 9.23% | 祥生医疗 | 28.56% | 行业排名> |
2017-06-30 | 1.13% | -66.07% | -38.25% | 52/122 | 5.96% | XD心脉医 | 31.04% | 行业排名> |
2017-03-31 | 1.83% | -21.12% | -40.39% | 28/122 | 2.63% | 新华医疗 | 13.55% | 行业排名> |
2016-12-31 | 3.07% | -35.1% | -66% | 69/122 | 16.13% | 安旭生物 | 48.71% | 行业排名> |
2016-09-30 | 9.03% | -1.53% | 171.17% | 16/122 | 8.61% | 迈瑞医疗 | 38.33% | 行业排名> |
2016-06-30 | 3.33% | -59.73% | 43.53% | 33/122 | 6.09% | 明德生物 | 14.54% | 行业排名> |
2016-03-31 | 2.32% | -54.51% | -50.95% | 15/122 | 2.17% | 迈瑞医疗 | 11% | 行业排名> |
2015-12-31 | 4.73% | -74.81% | -48.42% | 53/122 | 15.52% | 安旭生物 | 59.22% | 行业排名> |
2015-09-30 | 9.17% | -39.71% | 10.88% | 12/122 | 7.48% | 大博医疗 | 30.55% | 行业排名> |
2015-06-30 | 8.27% | 3.89% | 62.16% | 15/122 | 7.5% | 基蛋生物 | 23.11% | 行业排名> |
2015-03-31 | 5.1% | 32.12% | -72.84% | 9/122 | 3.22% | 基蛋生物 | 11.34% | 行业排名> |
2014-12-31 | 18.78% | 22.03% | 23.47% | 22/122 | 17.15% | -- | -- | 行业排名> |
2014-09-30 | 15.21% | 32.38% | 91.08% | 6/122 | 9.2% | -- | -- | 行业排名> |
2014-06-30 | 7.96% | 36.77% | 106.22% | 10/122 | 7.26% | -- | -- | 行业排名> |
2014-03-31 | 3.86% | 27.39% | -74.92% | 4/122 | 2.1% | -- | -- | 行业排名> |
2013-12-31 | 15.39% | 40.16% | 33.94% | 26/122 | 17.8% | -- | -- | 行业排名> |
2013-09-30 | 11.49% | 26.68% | 97.42% | 6/122 | 7.56% | -- | -- | 行业排名> |
2013-06-30 | 5.82% | -5.52% | 92.08% | 11/122 | 4.75% | -- | -- | 行业排名> |
2013-03-31 | 3.03% | 83.64% | -72.4% | 9/122 | 1.73% | -- | -- | 行业排名> |